Enter the details of the role here to advertise on the site for free.
Submit a Vacancy
Principle Medical Writer
Company: 30 Technology
The role of Principal Medical Writer at 30 Technology is a critical role to support the development and maintenance of clinical and regulatory documentation as well as writing successful grant applications. You will be a strategically important member of the team playing a key role in writing clinical and regulatory documentation, securing future funding, collaborating directly with public bodies and other organisations on large scale projects.
This role could be based in London or Oxford, UK.
Responsible for writing high quality clinical and regulatory documentation, including but not limited to protocols, investigator brochures, informed consent forms, development safety update reports and study manuals
Support the development of regulatory submission documentation, including CTA, IND and NDA deliverables to ensure project timelines are me
Facilitate interactions with regulatory authorities including compilation of responses
Write manuscripts for publication in peer-reviewed journals
Lead development of conference deliverables, including abstracts, posters and slide decks
Developing and securing funding for highly technical business ideas through finding and selecting relevant grants
Collating and assimilating complex data and information to write high impact, winning grant applications
Administration of the application process, including communication associated with each grant and the relevant funding body
Developing an efficient and effective grant writing process, building relationships and liaise effectively with internal and external experts
Regular, ongoing cooperation with a variety of internal and external experts including scientific and finance
Achieve editorial excellence, producing clear, accurate, grammatically correct and creative written work
You will have strong medical writing skills coupled with a strategic mindset and a sharp focus on delivery to succeed in this role.
Bachelor’s degree in a scientific or technical subject with 5+ years medical writing experience working in a scientific, technology-oriented environment
Be able to demonstrate a strong record of successful grant delivery through organisations such as Innovate UK, Horizon 2020 etc.
Excellent attention to detail
Understanding of US and EU regulatory requirements
High motivation, excellent organisation and communication skills with outstanding levels of creativity and persuasive ability
30 Technology was created as a group of seven wholly owned subsidiaries aligned to its research programs and market verticals:
30Respiratory, 30Woundcare, 30Therapeutics, 30Pharma, 30Dermatology, 30AnimalHealth and 30Innovation.
30 Technology aim to unlock and deliver the promise of therapeutic nitric oxide by developing and defining new models of care to treat many serious medical conditions by enhancing the body’s healing and defence mechanisms.
Nitric oxide (NO) is a volatile gas, produced in tissues of the body, which acts as a vital cell-to-cell signaling mechanism. The discovery NO is involved in a number of critical physiological processes led to a 1998 Nobel Prize. Since then, a number of attempts have been made to harness its multiple therapeutic effects which include increased blood flow, regulation of immune response, abroad-spectrum anti-microbial activity and acceleration of healing.
However, NO has a very short half-life, so sustained release and practical delivery is difficult to attain. 30 Technology has solved these previously intractable problems, utilizing proprietary IP to create a platform technology which uniquely creates the opportunity to use NO in a variety of diseases and health conditions.
Additionally, our revolutionary 30TechnologyTM Intellectual Property allows us to deliver sustained NO into the lung via aerosol, through the skin via topical patches, gels, liquids and into the body for release from biomaterials in regenerative medicine.
Our technology is clinically proven and a potent solution to many serious medical conditions.
To achieve its goals, 30 Technology has been highly successful in its first round of funding, raising more than £30m. The lead investor is Morningside Ventures, the Harvard, Boston-based Lifescience VC with an international reputation.
30 Technology is an equal opportunity employer. All applicants will be considered for employment without attention to race, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status.
To apply for this vacancy please get in touch with the recruiter using the details shown above.